2025
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
Penzel N, Polosecki P, Addington J, Arango C, Asgari-Targhi A, Billah T, Bouix S, Calkins M, Campbell D, Cannon T, Castro E, Cho K, Coleman M, Corcoran C, Dwyer D, Frangou S, Fusar-Poli P, Glynn R, Haidar A, Harms M, Jacobs G, Kambeitz J, Kapur T, Kelly S, Koutsouleris N, Abhinandan K, Kucukemiroglu S, Kwon J, Lewandowski K, Li Q, Mantua V, Mathalon D, Mittal V, Nicholas S, Pandina G, Perkins D, Potter A, Reichenberg A, Reinen J, Sand M, Seitz-Holland J, Shah J, Srinivasan V, Srivastava A, Stone W, Torous J, Vangel M, Wang J, Wolff P, Yao B, Anticevic A, Wolf D, Zhu H, Bearden C, McGorry P, Nelson B, Kane J, Woods S, Kahn R, Shenton M, Cecchi G, Pasternak O. Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia 2025, 11: 53. PMID: 40180950, PMCID: PMC11968818, DOI: 10.1038/s41537-025-00561-w.Peer-Reviewed Original ResearchCHR syndromeClinical assessmentCHR individualsClinical high riskTransition to psychosisBaseline clinical assessmentClinical endpointsMultidisciplinary team of expertsAnalysis planHigh riskSample of individualsMultimodal biomarkersLongitudinal clinical assessmentsClinical trajectorySchizophrenia ProgramMultidisciplinary teamBaseline assessmentSyndromeDifferentiate subgroupsCommunity controlsBiomarkersPsychosisAMPBaselineTeam of experts
2024
Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1
Mannes P, Adams T, Farsijani S, Barnes C, Latoche J, Day K, Nedrow J, Ahangari F, Kaminski N, Lee J, Tavakoli S. Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1. Science Advances 2024, 10: eadm9817. PMID: 38896611, PMCID: PMC11186491, DOI: 10.1126/sciadv.adm9817.Peer-Reviewed Original ResearchConceptsIdiopathic pulmonary fibrosisFibrotic lung diseaseRisk stratificationMurine modelLung fibrosisLung diseaseModel of bleomycin-induced lung fibrosisBleomycin-induced lung fibrosisImaging biomarkersMurine model of bleomycin-induced lung fibrosisBronchoalveolar lavage cellsMonocyte-derived macrophagesPositron emission tomographyInflammatory endotypesPulmonary fibrosisLavage cellsPoor survivalNoninvasive assessmentTherapeutic monitoringEmission tomographyCMKLR1FibrosisClinical trajectoryLungLung regionsPrognostic Implications of Early Prediction in Posttraumatic Epilepsy
Chen Y, Cappucci S, Kim J. Prognostic Implications of Early Prediction in Posttraumatic Epilepsy. Seminars In Neurology 2024, 44: 333-341. PMID: 38621706, DOI: 10.1055/s-0044-1785502.Peer-Reviewed Original ResearchPosttraumatic epilepsyTraumatic brain injuryComplication of traumatic brain injuryRisk of posttraumatic epilepsyPosttraumatic epilepsy modelBrain injuryPrognostic implicationsPrognostic informationIncreased morbidityClinical trajectoryTreatment strategiesPatient's clinical trajectoryRisk factorsHigh riskQuantitative prognostic information
2023
Spatiotemporal Correlation between Amyloid and Tau Accumulations Underlies Cognitive Changes in Aging
Kim C, Diez I, Bueichekú E, Ahn S, Montal V, Sepulcre J. Spatiotemporal Correlation between Amyloid and Tau Accumulations Underlies Cognitive Changes in Aging. Journal Of Neuroscience 2023, 44: e0488232023. PMID: 38123362, PMCID: PMC10869152, DOI: 10.1523/jneurosci.0488-23.2023.Peer-Reviewed Original ResearchConceptsHarvard Aging Brain StudyCognitive changesCognitive declineAssociated with cognitive changesAssociated with early cognitive declineAging Brain StudyEarly cognitive declineTau depositionCognitive scoresBrain studiesHuman brainTau pathologyOlder adultsTau accumulationTau associationImpaired associationAD symptomsClinical trajectoryCortical patternsTauBraak stageSpatiotemporal levelsTemporal accumulationBraakFuture increases
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply